In the GFP control group, approximately 30% of the mice died in the first week after stroke onset, while the mortality rate in the NeuroD1-treated mice decreased to 4.5%, and only one out of twenty-two mice died from ischemic stroke (Fig. 7B). This evidence concerns the gene NEUROD1 and stroke disorder.